📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

QuidelOrtho Corp

Common Name
QuidelOrtho
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
6,600
Ticker
QDEL
Exchange
NASDAQ/NGS
Description
QuidelOrtho Corporation is a leading manufacturer and provider of diagnostic testing solutions that serve the healthcare industry on a global scale. The company focuses on developing innovative diagno...

QuidelOrtho's GHG Emissions Data Preview

In 2023, QuidelOrtho completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, QuidelOrtho has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=QDEL&reporting_period=2024"

Verified Sources Behind QuidelOrtho’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore QuidelOrtho’s data sources below and access millions more through our Disclosure Search.

a. QuidelOrtho's Sustainability Report 2023
a. QuidelOrtho's Sustainability Report 2023

Insights into QuidelOrtho's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions ofQuidelOrtho amounted to50,553metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of QuidelOrthodecreased by 4.84%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

QuidelOrtho's Scope 1 Emissions Over Time

2022202307 k14 k21 k28 ktCO2e-14%
  • Total Scope 1
  • Year-over-Year Change

What are QuidelOrtho's Scope 1 emissions?

In 2023, the total Scope 1 emissions of QuidelOrtho were 22,544 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Compared to the previous year(2022), QuidelOrtho's Scope 1 emissions decreased by 13.99%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are QuidelOrtho's Scope 2 emissions?

In 2023, QuidelOrtho reported Scope 2 greenhouse gas (GHG) emissions of 29,690 tCOâ‚‚e using the market-based method and 28,009 tCOâ‚‚e using the location-based method.a

Has QuidelOrtho reduced its Scope 2 emissions over time?

Compared to the previous year(2022), QuidelOrtho's Scope 2 emissions(Location-Based) have remained relatively stable, indicating that QuidelOrtho's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does QuidelOrtho use for Scope 2 reporting?

In 2023, QuidelOrtho reported its Scope 2 emissions using the market-based method and using the location-based method.a

QuidelOrtho's Scope 2 Emissions Over Time

2022202307.5 k15 k22.5 k30 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into QuidelOrtho’s GHG Emissions Intensity Compared to Industry Peers

In 2023, QuidelOrtho reported Scope 1 greenhouse gas (GHG) emissions of 22,544 tCOâ‚‚e and total revenues of USD 2,998 millions. This translates into an emissions intensity of 7.52 tCOâ‚‚e per millions USD.a

QuidelOrtho's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)IInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MModernaYear: 2024Scope 1: 13,180 tCO2eRevenue: $M 3,199Scope 1 Intensity: 4.12 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$M

How does QuidelOrtho's GHG emissions intensity compare to its peers?

In 2023, QuidelOrtho reported a Scope 1 emissions intensity of 7.52 tCOâ‚‚e per millions USD. Compared to the peer group median of 2.65, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does QuidelOrtho rank on GHG emissions intensity within its industry?

In 2023, QuidelOrtho ranked 20 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places QuidelOrtho among the least efficient performers, with one of the highest emissions intensities in its sector.a

Want Full Access to QuidelOrtho's GHG Emissions Dataset?
Sign Up